4D Bioprinting Global Market Report 2024

The 4D bioprinting market size has grown exponentially in recent years. It will grow from $0.07 billion in 2023 to $0.09 billion in 2024 at a compound annual growth rate (CAGR) of 30.3%. The growth observed during the historical period can be attributed to several factors, including the rise in the geriatric population, increasing healthcare expenditure, a surge in 3D bioprinting startups, growing investments in research and development (R&D), and the escalating prevalence of chronic diseases.

The 4D bioprinting market size is expected to see exponential growth in the next few years. It will grow to $0.26 billion in 2028 at a compound annual growth rate (CAGR) of 29.9%. The projected growth in the forecast period can be linked to several key factors, including the increasing demand for organ transplants, a rising aging population, the increasing prevalence of chronic diseases, escalating healthcare expenditure, and a growing demand for personalized medicine. Major trends expected during this period include technological advancements, collaborations between academia and industry, the integration of artificial intelligence, a shift towards decentralized manufacturing, and the integration with 3D imaging technologies.

The burgeoning demand for organ transplants is poised to propel the expansion of the 4D bioprinting market in the foreseeable future. Organ transplants entail the surgical transfer of organs or tissues from a donor to a recipient afflicted by organ failure or dysfunction, aiming to save lives and enhance quality of life. Utilizing 4D bioprinting, organ transplant procedures advance regenerative medicine by precisely constructing intricate tissues and organs endowed with functional capabilities. This technology offers promising solutions to mitigate the shortage of donor organs and enhance transplant outcomes. Notably, in January 2022, data from the Organ Procurement and Transplantation Network (OPTN), a US-based governmental body, indicated a notable increase in organ transplantations conducted in the United States, reaching 41,354 procedures, marking a 5.90% rise from the preceding year. Hence, the escalating demand for organ transplants emerges as a pivotal driver propelling the growth of the 4D bioprinting market.

The rising prominence of personalized medicine is anticipated to drive the expansion of the 4D bioprinting market in the forthcoming years. Personalized medicine adopts a tailored medical approach that customizes healthcare decisions, interventions, and treatments according to individual patient characteristics. 4D bioprinting assumes a critical role in personalized medicine by facilitating the fabrication of intelligent, environmentally responsive biological structures, tissues, and organs capable of adapting to diverse environmental stimuli. Notably, in 2022, data from the Personalized Medicine Coalition, a US-based professional organization, highlighted a significant increase in the approval of personalized medicines, accounting for approximately 34% of all newly approved therapies. This marks a substantial uptick from previous years, underscoring the growing demand for personalized medical solutions and subsequently driving the growth trajectory of the 4D bioprinting market.

Leading enterprises in the 4D bioprinting sector are forging strategic alliances to streamline the printing of micro-scale geometries. These collaborations with fellow entities or organizations offer access to specialized equipment, facilities, and resources that might otherwise be prohibitively expensive or challenging to obtain independently, thereby facilitating more robust research and development endeavors. For instance, in December 2021, 4D Biomaterials, a UK-based chemical manufacturing firm, entered into a partnership with Boston Micro Fabrication (BMF), a US-based company specializing in micro precision 3D printing. The collaborative venture between 4D Biomaterials and Boston Micro Fabrication aims to revolutionize the production of implantable medical devices by enabling micro 3D printing applications utilizing 4Degra bioresorbable materials. This strategic alliance merges BMF's microscale 3D printing systems with 4D Biomaterials' 4Degra resin inks, facilitating the printing of micro-scale geometries for a myriad of medical device applications, ranging from rigid orthopedic devices to soft tissue applications.

Major companies operating in the 4d bioprinting market are 3D Systems Corporation, CELLINK AB, EnvisionTEC Inc., Advanced Solutions Life Sciences, Nanoscribe, Aspect Biosystems Ltd., Aleph Farms, BioBots Inc., Sculpteo, Prellis Biologics, Rokit Healthcare, Cyfuse Biomedical, 3D Bioprinting Solutions, 4D Biomaterials Ltd., Allevi Inc., Cellenion, FluidForm, Methuselah Health, Nanofabrica, OxSyBio Ltd., Poietis S.A.S., REGEMAT 3D S.L., Replicel Life Sciences Inc., VIVAX BIO, Organovo Holdings Inc.

North America was the largest region in the 4D bioprinting market in 2023. The regions covered in the 4d bioprinting market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the 4d bioprinting market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

4D bioprinting represents an advanced manufacturing technique that combines 3D bioprinting with dynamic functionalities, enabling the creation of biomimetic structures capable of adapting shape or function over time in response to external stimuli. This technology facilitates the fabrication of tissues and structures that can emulate the dynamic functionalities of natural tissues.

The primary technologies utilized in 4D bioprinting include extrusion-based, laser-based, inkjet-based, and other methodologies. Extrusion-based technology involves selectively dispensing material through a nozzle or orifice to build a three-dimensional object, serving various applications including biomedical uses. These applications are employed by pharmaceutical and biotechnology companies, academic research and development institutions, among others.

The 4D bioprinting market research report is one of a series of new reports that provides 4D bioprinting market statistics, including 4D bioprinting industry global market size, regional shares, competitors with a 4D bioprinting market share, detailed 4D bioprinting market segments, market trends and opportunities, and any further data you may need to thrive in the 4D bioprinting industry. This 4D bioprinting market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The 4D bioprinting market consists of revenues earned by entities providing services such as consulting, design, and customization of 4D bio printed products.The market value includes the value of related goods sold by the service provider or included within the service offering. The 4D bioprinting market also includes sales of 4D bioprinters and related consumables such as bioinks and biomaterials. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.